Papillary thyroid carcinoma: Rationale for hemithyroidectomy

Textbook of Endocrine Surgery

Volumn , Issue , 2005, Pages 102-109

  Fujimoto, Yoshihide ^a,b   Obara, Takao ^a,c   Okamoto, Takahiro ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882472175     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0139-7.50015-6     Document Type: Chapter

References (62)

1. Cady B, Rossi RL An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988, 104:947.
2. De Groot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990, 71:414.
3. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986, 61:978.
4. Samaan NA, Maheshwari YK, Nader S, et al. Impact of therapy for differentiated carcinoma of the thyroid: Analysis of 706 cases. J Clin Endocrinol Metab 1983, 56:1131.
5. Wanebo HJ, Andrews W, Kaiser DL Thyroid cancer: Some basic considerations. Am J Surg 1981, 142:474.
6. Harada T, Shimaoka K, Yakumaru K, et al. Prognosis of thyroid carcinoma. Int Adv Surg Oncol 1981, 4:83.
7. Ito J, Noguchi S, Murakami N, et al. Factors affecting the prognosis of patients with carcinoma of the thyroid. Surg Gynecol Obstet 1980, 150:539.
8. Noguchi S, Murakami N, Kuwamoto H Classification of papillary cancer of the thyroid based on prognosis. World J Surg 1994, 18:552.
9. Carcangiu ML, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid: A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985, 55:805.
10. Hennequin P, Liehn JC, Delisle MJ Multifactorial analysis of survival in thyroid cancer: Pitfalls of applying the results of published studies to another population. Cancer 1986, 58:1749.
11. Hoie J, Stenwig AE, Brennhord IO Surgery in papillary thyroid carcinoma: A review of 730 patients. J Surg Oncol 1988, 137:147.
12. Schelfhout LJDM, Creutzberg CL, Hamming JF, et al. Multivariate analysis of survival in differentiated thyroid cancer: The prognostic significance of the age factor. Eur J Cancer Oncol 1988, 24:331.
13. Tennval J, Biorklund A, Moller T, et al. Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma?. Cancer 1986, 57:1405.
14. Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985, 55:794.
15. Cady B, Sedgwick CE, Meissner WA, et al. Risk factor analysis in differentiated thyroid cancer. Cancer 1979, 43:810.
16. Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987, 102:1088.
17. Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma: A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979, 15:1033.
18. Hermaneck P, Sobin LH TNM Classification of Malignant Tumours: International Union Against Cancer 1987, Springer-Verlag, New York. 4th ed.
19. Beahrs OH, Henson DE, Hutter RVP, et al. Manual for Staging of Cancer: American Joint Commission in Cancer 1988, JB Lippincott, Philadelphia. 3rd ed.
20. Hay ID Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990, 19:545.
21. Lorentz TG, Lau PWK, Lo CY, et al. Multivariate analysis of risk factors influencing survival in 110 ethnic Chinese with papillary thyroid carcinoma. World J Surg 1994, 18:547.
22. Shah JP, Loree TR, Dharker D, et al. Prognostic factors in a differentiated carcinoma of the thyroid. Am J Surg 1992, 164:658.
23. Clark OH TSH suppression in the management of thyroid nodules and thyroid cancer. World J Surg 1981, 5:39.
24. Fujimoto Y, Obara T, Ito Y, et al. Endocrine surgery in Japan and in our series. Endocrine Surg (Tokyo) 1988, 5:423.
25. Takai S Controversial issues regarding the management of papillary thyroid carcinoma. Thyroidol Clin Exp 1998, 10:109.
26. Boley SJ, Cady B, Mazzaferri EL, et al. Symposium: Management of thyroid neoplasm. Contemp Surg 1993, 43:369.
27. Clark OH Total thyroidectomy. The treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982, 196:361.
28. Ezaki H, Ebihara S, Fujimoto Y, et al. Analysis of thyroid carcinoma based on material registered in Japan during 1977-1986 with special reference to predominance of papillary type. Cancer 1992, 70:808.
29. Rossi RL, Cady B Differentiated carcinoma of thyroid gland. Surgery of the Thyroid and Parathyroid Glands 1991, 139. WB Saunders, Philadelphia. 3rd ed. B. Cady, R.L. Rossi (Eds.).
30. Bacher-Stier C, Riccabonna G, Totsch M, et al. Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 1997, 7:733.
31. Scheumann GFW, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994, 18:559.
32. Bubenhofer R, Hedinger C Schilddrüsenmalignome vor und nach Einführung der Jodsalzprophylaxe. Schweiz Med Wochenschr 1977, 107:733.
33. Krisch K Schilddrüsentumoren. Zur Morphologie maligner Schilddrüsentumoren. Ein retrospective Studie anhand von 981 Fallen mit Berücksichtigung des Einflusses der Jodsalz-Prophylaxe 1983, Karger, Basel.
34. Belfiore A, Rosa GLL, Padova G, et al. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 1987, 60:3096.
35. Koutras DA The present status of endemic goiter as a problem of the public health-Europe. Endemic Goiter and Endemic Cretinism 1980, 79. Wiley, New York. J.B. Stanbury, B.S. Hetzel (Eds.).
36. Oddic TH, Fisher DA, McConahey WM, et al. Iodine intake in the United States: A reassessment. J Clin Endocrinol Metab 1970, 30:659.
37. Nagataki S Thyroid function in the normal Japanese. Igakuno Ayumi (Progr Med) 1970, 72:621.
38. Cady B, Cohen K, Rossi RL, et al. The effect of thyroid hormone administration upon survival in patients with differentiated thyroid carcinoma. Surgery 1983, 94:978.
39. Vickery AL, Wang C-A, Walker AM Treatment of intrathyioidal papillary carcinoma of the thyroid. Cancer 1987, 60:2587.
40. Fujimoto Y, Sugitani I Postoperative prognosis of intrathyroidal papillary thyroid carcinoma: Long-term (35-45 year) follow-up study. Endocrine J 1998, 45:475.
41. Mazzaferri EL, Young RL, Oertel JE, et al. Papillary thyroid carcinoma: The impact of therapy in 576 patients. Medicine 1977, 56:171.
42. Grant CS, Hay ID, Gough IR, et al. Local recurrence in papillary thyroid carcinoma: Is extent of surgical resection important?. Surgery 1988, 104:954.
43. Russell WO, Ibanez ML, Clark RL, et al. Thyroid carcinoma: Classification, intraglandular dissemination, and clinicopathologic study based upon whole organ sections of 80 glands. Cancer 1963, 16:1425.
44. Katoh R, Sasaki J, Kurihara H, et al. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma: A clinicopathologic study of 105 consecutive patients. Cancer 1992, 70:1585.
45. Clark OH Thyroid nodules and thyroid cancer. Endocrine Surgery on the Thyroid and Parathyroid Glands 1985, 56. CV Mosby, St. Louis. O.H. Clark (Ed.).
46. Mazzaferri EL Papillary thyroid carcinoma: Factors influencing prognosis and current therapy. Semin Oncol 1987, 14:315.
47. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993, 114:1050.
48. Fujimoto Y, Obara T, Ito Y, et al. Diffuse sclerosing variant of papillary carcinoma of the thyroid: Clinical importance, surgical treatment, and follow-up study. Cancer 1990, 66:2306.
49. Matoba N, Kikuchi T Thyroidolymphography: A new technique for visualization of the thyroid and cervical lymph nodes. Radiology 1969, 92:339.
50. Frankenthaler RA, Sellin RV, Cangir A, et al. Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg 1990, 160:341.
51. Harness JK, Thompson NW, McLeod MK, et al. Differentiated thyroid carcinoma in children and adolescents. World J Surg 1992, 16:547.
52. Cady B Surgery of thyroid cancer. World J Surg 1981, 5:3.
53. Mori Y, Takaya K, Miyata Y, et al. Induction of discriminant function concerning postoperative local recurrence or distant metastasis in 589 patients with differentiated thyroid cancer. Jpn J Surg 1993, 23:777.
54. Noguchi S, Noguchi A, Murakami N Papillary carcinoma of the thyroid: I. Development of metastasis. Cancer 1970, 26:1053.
55. Noguchi S, Murakami N The value of lymph node dissection in patients with differentiated thyroid cancer. Surg Clin North Am 1987, 67:251.
56. Fujimoto Y, Oka A, Uchida H, et al. Reevaluation of the effect of TSH suppression therapy on differentiated thyroid cancer. Shindan-to-Chiryo (Diagn Ther) 1968, 56:473.
57. Fujimoto Y, Oka A, Tanaka K, et al. Plasma TSH levels in patients who underwent thyroidectomy for thyroid carcinoma: Reevaluation of TSH suppression therapy. Geka-Shinryo (Surg Clin) 1976, 118:792.
58. Mazzaferri EL Management of solitary thyroid nodule. N Engl J Med 1993, 328:553.
59. Fujimoto Y, Obara T, Ito Y, et al. Aggressive surgical approach for locally invasive papillary carcinoma of the thyroid in patients over forty-five years of age. Surgery 1986, 100:1098.
60. Ishihara T, Yamazaki S, Kobayashi K, et al. Resection of the trachea infiltrated by thyroid carcinoma. Ann Surg 1982, 195:496.
61. Nakao K, Miyata M, Izukura M, et al. Radical operation for thyroid carcinoma invading the trachea. Arch Surg 1984, 119:1046.
62. Yang C-C, Lee C-H, Wang L-S, et al. Resectional treatment for thyroid cancer with tracheal invasion. Arch Surg 2000, 135:704.